It's the Brian Larrow Show on WNYC.

Good morning again, everyone.

Now we'll look at some of the human cost of the Trump administration's USAID pause back in January of this year. Last week,

the Washington Post, maybe you've seen it, published an extensive investigation that found

nearly $140 million in HIV and malaria medications were delayed or never delivered, and the

children died while those medicines sat in warehouses,

miles from the clinics that needed them.

Joining me now to share her team's reporting on this is Meg Kelly, reporter at the Washington Post.

Meg, thank you for coming on. Welcome to WNYC.

Thanks so much for having me, Brian.

First, help us understand the timeline here.

The Trump administration paused foreign aid back in January shortly after he returned to the White House.

There was a public reversal within days, so to be clear on that.

But how long did the disruptions actually last? And big picture what happened during that period.

Sure. So as you said, you know, as soon as the president came back into office, he, you know,

put this 90-day pause in place. And then within days, you know, Marco Rubio said,

life-saving aid is going to continue.

We're going to keep pushing forward this aid.

What became tricky in there is each program needed its own waiver.

So there were plenty of programs that people and advocates said, hey, this qualifies as life-saving aid and should continue. The program that we looked at

is called the global health supply chain. It, you know, has an annual budget of more than $900 million

just for HIV and malaria aid, which are the pieces of it that the administration considered to be

...